Overall, dependency on ADAM10 was demonstrated in seven out of eight AL PDX models in vivo, suggesting that ADAM10 plays an essential role in both types of acute leukemia, ALL and AML, independent of the molecular subtype or genetic abnormalities (Table S1). This evidence concerns the gene ADAM10 and acute lymphoblastic leukemia.